In a randomized , double blind , parallel groups design participants received either placebo ( @mg/day ; n = @ ) , modafinil ( @mg/day ; n = @ ) , escitalopram ( @mg/day ; n = @ ) , or modafinil + escitalopram ( @ +@ mg/day ; n = @ ) for @ days .